Latest Content

In part 2, Blank argues that the language on a medication’s label deserves the same regulatory scrutiny given to the drugs themselves and how they affect patients.

Viatris' new transdermal patch adds a low-dose estrogen option to the contraceptive landscape.

A study found antibody deficiencies and monoclonal immunoglobulins in a share of adults hospitalized with invasive pneumococcal disease.

Researchers explore prenatal alcohol use among expectant mothers in the US spanning 2011 to 2024.

A 4-year cohort study finds pneumococcal vaccine serotypes circulating and increasing among older adults with community-acquired pneumonia.

Study findings underscore health care’s gradual push into the technologically driven future of health care, leaving in-store destinations behind.

Managing diabetes has shifted from reactive monitoring to a proactive, technology-driven standard of care that emphasizes real-time data and personalized treatment.

Sharon Blank, CEO of RxTran and Language Scientific, discusses language hurdles in the safe delivery of medications for patients and pharmacists alike.

The opioid-free product pairs acetaminophen with naproxen in a single dose, giving pharmacists a new counseling point for patients.

Researchers design, implement, and evaluate the use of social determinants of health screening and referral services within Medicaid payer programs.

Positive results from TRIUMPH-2 and TRIUMPH-3 bring retatrutide's obesity program to 5 successful trials, with Lilly planning to submit in early 2027.

Pharmacists were asked about their perceived knowledge and attitudes toward patients with Down syndrome.

The autoinjector cuts administration to under 10 seconds, offering patients an at-home option for fluid overload in heart failure and chronic kidney disease.

A new survey shows widespread uncertainty about which vaccines the CDC recommends during pregnancy, underscoring the counseling role pharmacists play.

In the first of a 2-day hearing on peptide therapy access, the FDA votes in favor of approving 4 of the products discussed, with the potential for more on Friday.

Experts collaborate on the best approaches for boosting immunization rates in populations across school campuses and shared living facilities.

As the pharmacist’s role continues to expand throughout health care, they are now being challenged to step in as opioid stewards in a rapidly evolving pain management landscape.

Through pharmacists’ statewide billing capabilities, researchers explore how educational support impacts community pharmacies’ medical billing.

New policies urge pharmacists to identify disinformation and seek legal protection against AI-generated impersonation.

Detailed results show the investigational islatravir/lenacapavir combination sustained virologic suppression as a potential once weekly HIV treatment.

Through the lens of pharmacist satisfaction, researchers assess the implementation and real-world use of medication alert systems.

In part 2, Richard Dion, PharmD, addresses some of the persistent challenges among hospital pharmacies and their pain management models, offering some expert solutions to move forward.

This episode explores PBMs’ copay collection discrepancies and how improper documentation can be the downfall for pharmacy business.

Pharmacists and other clinicians counseling postpartum patients may find more success with meal-timing strategies that require minimal disruption to routines.

A new report on glucagon-like peptide-1 receptor agonists for obesity finds real clinical value alongside budget impact that already exceeds the review's own threshold.

Immunology expert Paul Licciardi, PhD, weighs in on the current state of recommended pneumococcal vaccines and what is on the horizon in the developmental stage.

Vaccine guidance in the US is undergoing a dramatic change, leaving pharmacists uncertain about coverage, authority, and flu-season timing.

In part 2, Paul Licciardi, PhD, dives into the evolving need for updated pneumococcal vaccine recommendations and how pharmacists can keep their patients informed.

A secret shopper study finds most are still compounding semaglutide and tirzepatide with additives, often through suppliers lacking sterile compounding licenses.

Richard Dion, PharmD, joins to discuss the growing prominence of opioid stewardship and where the pharmacist can assist in patient programming.

Analyzing nearly a decade of pharmaceutical interventions in community pharmacies, researchers reveal the role pharmacists play in self-medication.